Crop Life Science Ltd has announced the regularization of Ms. Sheetalben Rachit Shah as a Non-Executive Independent Director for a period of five years, effective from April 10, 2026. The appointment was approved by shareholders through a postal ballot process, which concluded on June 24, 2026, with 99.97% of votes cast in favour. This move strengthens the company's governance framework following her initial appointment as an Additional Director by the Board.

The resolution received overwhelming support, with the promoter group casting all 12,000,000 shares in favour. Public non-institutional shareholders also supported the appointment, with 680,000 votes in favour and 4,000 against. A total of 13 members participated in the e-voting process, casting 12,684,000 votes.

Voting Results Breakdown

The detailed voting results highlight the consensus among shareholders regarding the director's appointment.

Regulatory Compliance and Procedure

The postal ballot was overseen by Mr. Ranjit Kumar Singh, a Practicing Company Secretary and Proprietor of Ranjit & Associates, serving as the Scrutinizer. The voting period was open from May 26, 2026, to June 24, 2026. The notice for the postal ballot was dispatched on May 21, 2026, and public advertisements were published in the Financial Express Newspaper on May 22, 2026. The record date for determining eligibility was May 15, 2026.

Ms. Sheetalben Rachit Shah possesses experience in management, administration, and business operations, with expertise in strategic planning and corporate governance. The company confirmed that she is not debarred from holding the office of Director by any order passed by SEBI or other authorities. The detailed voting results and the Scrutinizer's report have been made available on the company's website and the NSE website.

Crop Life Science reported a net profit of ₹698.69 lakh for the year ended March 31, 2026, an increase from ₹662.03 lakh in the previous year. Revenue from operations rose to ₹20,717.42 lakh from ₹20,059.00 lakh in FY25. The company's basic and diluted earnings per share stood at ₹4.08 for the year, compared to ₹3.86 in the prior year.

Financial Performance

The total income for the year grew to ₹20,888.52 lakh from ₹20,157.16 lakh in the previous year. Total expenses increased to ₹19,904.37 lakh from ₹19,256.08 lakh. The profit before tax for the year was reported at ₹990.43 lakh, up from ₹900.99 lakh in FY25.

Segment Information

The company operates in two business segments: manufacturing and dealing in pesticides, insecticides, herbicides, fertilizers, and allied products related to research and technical formulations; and trading of agro products. For the consolidated financial statements, the company considered agro chemicals as the only reportable segment as trading activities did not meet the quantitative thresholds prescribed under Ind AS 108.

Consolidated Results

On a consolidated basis, the company reported a net profit of ₹649.49 lakh for the year ended March 31, 2026, compared to ₹560.11 lakh in the previous year. Total revenue from operations for the group stood at ₹20,717.42 lakh. The profit attributable to the owners of the company was ₹663.51 lakh, while non-controlling interest was reported at a loss of ₹14.02 lakh.

Board Approval and Auditor's Report

The Board of Directors approved the audited standalone and consolidated financial statements and results for the half year and year ended March 31, 2026 at its meeting held on May 26, 2026. The statutory auditors, Shah & Shah Chartered Accountants, issued an audit report with an unmodified opinion on the standalone and consolidated financial results.